77.1%
in situ immunotherapycancerELI-004ELI-002
…cific products. To circumvent these challenges and limitations, in situ immunotherapy administers immunostimulatory adjuvants directly into tumors, w…
7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed
All extracted treatments
Showing 3,661–3,720 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
interstitial wedge resection1interval cytoreductive surgery1intervention1interventional pain procedures1interventional radiology1interventional regional anesthesia1interventional therapies1interventional treatment1intestinal rehabilitation1intra-abdominal packing1intra-arterial (IA) chemotherapy1intra-arterial (IA) thrombectomy1intra-arterial chemical angioplasty1intra-arterial chemical treatment1intra-articular mesenchymal stem cells1intra-articular platelet-rich plasma injections1intra-articular steroid injections1intracranial angioplasty1intracranial vascular malformation embolizations1intracranial venous interventions1intracranial venous stenting1intrafascial injection1intragastric balloon1intralymphatic immunotherapy1intramedullary nailing1intramuscular treatment1intraosseous lunate decompression1intrapleural enzyme therapy1intrasaccular flow diversion1intrasphincteric Botulinum toxin injection1intrathecal and systemic chemotherapy1intrathecal immunotherapy1intrathecal therapy1intravascular intervention therapy1intravenous antibiotic therapy1intravenous antibiotic treatment1intravenous antiemetics1intravenous crystalloid and electrolyte supplements1intravenous dextrose1intravenous diuretics1intravenous fluid hydration1intravenous fluid resuscitation1intravenous glucose-containing fluids1intravenous immunoglobulin (IVIg) treatment1intravenous infusions1intravenous insulin therapy1intravenous iron infusion1intravenous tenecteplase (TNK) thrombolysis1intravenous vasopressor infusions1intravenous-to-oral switch therapy1intravitreal VEGF inhibitor therapy1intravitreal anti-vascular endothelial growth factor therapy1intravitreal antibiotic administration1intravitreal gas tamponade1intravitreal treatment1investigational drug management1involved-field radiotherapy1iodine-125 plaque radiotherapy1iron chelation1irrigation1
Articles mentioning treatments
7,227 articles · page 505 of 603anti-PD-1/PD-L1 therapiesThe Ohio State University Comprehensive Cancer CenterMerkel cell carcinomaOSUCCCPelotonia Institute for Immuno-OncologyMCCNational Institutes of HealthNIH
…ltration, MCC tumors often evade immune-mediated killing. While anti-PD-1/PD-L1 therapies are efficacious, MCC patients resistant or relapsing after immu…
adjuvant immunotherapiesLung cancer
…omarkers predictive of the likelihood of patients responding to adjuvant immunotherapies. Briefly, we applied cell segmentation and unbiased cell typing…
immune checkpoint blockadehepatocellular carcinomaUniversity of WashingtonFred Hutch Cancer CenterhAbChAbCs
…e PD1+ CXCL13+ T helper and TCF7+ progenitor CD8+ T cells after immune checkpoint blockade, suggesting interactions between these cells can overcome T cel…
TKIsselpercatinibcabozantinibvandetanibNew England Journal of MedicineClinical Cancer ResearchMedullary thyroid cancer (MTC)EACRIUC-DenverGFRA4+1 more
…r metastatic MTC. In the setting of progressive metastatic MTC, TKIs (selpercatinib, cabozantinib and vandetanib) can prolong surviv…
Chimeric Antigen Receptor T (CAR-T) cell therapyhematologic malignanciessolid tumors
…Background Chimeric Antigen Receptor T (CAR-T) cell therapy has emerged as an advanced and highly effective approach for tr…
combination chemotherapypancreatic cancerADoBindADoBind-MMAEADoBind-DM1MC001
…s than 50% of patients with advanced pancreatic cancer tolerate combination chemotherapy. Combining immune-mediated cytotoxicity with payload-mediated c…
epidural analgesiaVisual Analogue ScalesufentanilropivacaineFirst Affiliated Hospital of Soochow UniversityERMF
…ndomised controlled trial will enrol 424 parturients undergoing epidural analgesia for trial of labour. Participants will be randomised (1:1) to r…
immunomodulatory treatmentNintedanibHospital District of Helsinkiinterstitial lung disease (ILD)connective tissue disease–ILDs
…100 mg two times per day). Twenty-seven (87%) patients received immunomodulatory treatment at the time of PPF.Conclusions In our cohort, the underlying di…
non-invasive ventilationcerebral palsyCPCYP
…piratory support (continuous positive airway pressure (CPAP) or non-invasive ventilation) to aid airway clearance. 1 2 Published evidence is sparse.1 2 …
mannose-based dietgastro-oesophageal reflux diseasehypothyroidismauditory neuropathy
… in MOGS CDG (congenital disorder of glycosylation type IIb). A mannose-based diet led to partial improvement. This case highlights the importance…
MDItype 1 diabetesGAD-7diabetesGeneralized Anxiety Disorder-7
…action than CSII users (p=0.044) and lower diabetes burden than MDI users (p=0.044) after controlling for age and gender. Treatment…